Skip to main content
. Author manuscript; available in PMC: 2019 Jan 3.
Published in final edited form as: Nature. 2018 Mar 7;555(7696):387–391. doi: 10.1038/nature25748

Extended Data Table 2:

Comparison of EwS and BRCA-mutant cancers

Phenotype BRCA1/2 mutant cancers Ewing sarcoma
Sensitivity to DNA damaging agents
Sensitivity to PARP1 inhibitors
Hyperactivation of PARP1
Impaired homologous recombination
Accumumation of R-loops
High expression of EZH2